CTLM(R), 3D Laser Breast Imaging System, Demonstrates Significant Results When Imaging Dense Breasts

CTLM(R), 3D Laser Breast Imaging System, Demonstrates Significant Results When
Imaging Dense Breasts

FORT LAUDERDALE, Fla., Dec. 11, 2012 (GLOBE NEWSWIRE) -- Imaging Diagnostic
Systems, Inc. (OTC:IMDSD), a pioneer in laser breast imaging, announced today
that Clinical Imaging, a leading US based radiologist peer review journal, has
reviewed and accepted a paper that evaluates the results of CTLM® and
mammography when imaging dense breasts.

The recent paper accepted by Clinical Imaging focuses on imaging women with
heterogeneously and extremely dense breast tissue using both mammography and
CTLM®. CTLM® is an innovative 3D laser breast imaging system that utilizes
Diffuse Optical Tomography or "DOT" technology. The study demonstrated that
the addition of a CTLM® scan to a mammogram improved sensitivity rates of
detecting breast abnormalities considerably. The sensitivity rates ranged from
34.4% for mammography alone to 81.57% when CTLM® was added. Equating to over
double the sensitivity to detect abnormalities when imaging extremely dense
breasts (ACR BIRADS 4 breast composition classification). To access the free
abstract and the complete clinical paper for purchase, please go to
www.clinicalimaging.org and search under the heading for either "CTLM" or
"CTLM as an adjunct to mammography in the diagnosis of patients with dense
breast". Globally, 40-50% of the female population have mammographically dense
breasts and these recent results present the potential of CTLM® to assist the
imaging needs of women with any breast density.

Clinical Imaging provides widespread coverage of innovative technology, new
applications, and important issues concerning all diagnostic imaging
techniques. The journal investigates the relative merits of established and
developing diagnostic imaging technology, with regard to cost effectiveness,
safety, and propriety where specific disorders and physiological systems are
concerned. Clinical Imaging is a radiologist peer reviewed publication. From
ultrasound to MRI, Clinical Imaging provides crucial information for
radiologists, radiology residents, and radiologic technologists.

The paper's author, Dr. Jin Qi remarks, "Our data indicated that the imaging
of CTLM® was least affected by tissue density in breasts and provides
information about angiogenesis in breast lesions, especially in malignant
lesions, when used as an adjunct to mammography in heterogeneously dense
breasts and extremely dense breasts, sensitivity increased significantly." Dr.
Qi concluded, "this is a feature that could have a positive impact on women's
imaging across the globe." Dr. Qi is deeply involved with breast cancer in
China and works in the following departments; Radiology Department at Tianjin
Medical University Cancer Institute and Hospital, Key Laboratory of Breast
Cancer Prevention and Therapy of the Ministry of Education, and Key Laboratory
of Cancer Prevention and Therapy.

CEO of Imaging Diagnostic Systems, Inc., Linda Grable states, "IDSI is very
excited and honored to have a CTLM® paper accepted by a leading, well
respected American diagnostic imaging publication. The results display the
capability of CTLM® to be less impeded by dense breast tissue than mammography
and will eventually provide radiologists with a complimentary non radiation
based imaging tool; especially when dealing with dense breast tissue. And the
additional patient benefits consisting of no radiation, no breast compression,
and no injected contrast agents will hopefully aide with women's imaging needs
globally".

Imaging Diagnostic Systems, Inc. is the developer of the CTLM® system; a
revolutionary optical breast imaging device. Optical mammography is a diffuse
optical tomography (DOT) technique that aims at detecting breast cancer. The
CTLM® system utilizes patented continuous wave laser technology and computed
algorithms to create 3D images of the breast. The procedure is non-invasive,
painless, and does not expose the patient to ionizing radiation or painful
breast compression. The CTLM® system has received certification and licenses
to sell internationally through the following approvals; European CE marking,
Health Canada, China SFDA, UL, ISO 13485:2003, FDA export certification.
Marketing clearances pending are Mexico COFEPRIS and Russian GOST-R.

For more information, visit our website: www.imds.com

desc

The Imaging Diagnostic Systems, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=16214

As contemplated by the provisions of the Safe Harbor section of the Private
Securities Litigation Reform Act of 1995, this news release may contain
forward-looking statements pertaining to future, anticipated, or projected
plans, performances and developments, as well as other statements relating to
future operations. All such forward-looking statements are necessarily only
estimates or predictions of future results or events and there can be no
assurance that actual results or events will not materially differ from
expectations. Further information on potential factors that could affect
Imaging Diagnostic Systems, Inc. is included in the Company's filings with the
Securities and Exchange Commission. We expressly disclaim any intent or
obligation to update any forward-looking statements. 

Contact: Investor Relations, 954-581-9800

A photo accompanying this releaseis available at:
http://www.globenewswire.com/newsroom/prs/?pkgid=16212

CONTACT: Investor Relations: 954-581-9800

Imaging Diagnostic Systems, Inc. Logo
 
Press spacebar to pause and continue. Press esc to stop.